Paola Conti

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Raffaella Pacchiana · 4 shared papers, 2018–2026 · strength 0.63
   • Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
   • Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286↗
   • Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
2. Massimo Donadelli · 4 shared papers, 2018–2026 · strength 0.63
   • Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
   • Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286↗
   • Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
3. Chiara Borsari · 2 shared papers, 2023–2026 · strength 0.41
   • Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
   • Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286↗
4. Adriana Celesia · 1 shared paper, 2026 · strength 0.23
   • Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
5. Alessandra Fiore · 1 shared paper, 2026 · strength 0.23
   • Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
6. Andrea Galbiati · 1 shared paper, 2023 · strength 0.18
   • Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286↗
7. Stefania Forciniti · 1 shared paper, 2022 · strength 0.14
   • Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
8. Elisa Dalla Pozza · 1 shared paper, 2022 · strength 0.14
   • Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
9. Ilaria Dando · 1 shared paper, 2022 · strength 0.14
   • Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
10. Giovanna Butera · 1 shared paper, 2018 · strength 0.09
    • Paper Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensi… DOI 10.1016/j.bbamcr.2018.10.005↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.